An inspection by the Food and Drug Administration (FDA) was conducted at Gaylord Chemical Company, LLC in Tuscaloosa on Feb. 27, as reported by data available on the FDA’s website.
The review focused on the following categories:
- Drug Quality Assurance
- Monitoring of Marketed Animal Drugs, Feed, and Devices
According to the final report, Gaylord Chemical Company, LLC was not required to implement any corrective actions related to its management operations.
The FDA regularly inspects facilities nationwide to verify that workplaces and their products meet FDA-regulated standards and regulations designed to enhance public health. Results of these inspections are shared publicly.
The agency’s website states the FDA is the federal authority mainly tasked with regulating and ensuring the safety and quality of human and animal drugs, biological products, medical supplies and tobacco products.
Information for this article was sourced from the U.S. Food and Drug Administration. The original data is available here.
